Stock market analyst Sanjeev Agarwal of Dynamix Research is of the view that investors can buy Cipla Ltd stock with short term target of Rs 332.

According to analyst, the stock can be purchased at Rs 312 with stop loss of Rs 299.

Today, the stock of the company opened at Rs 314 on the Bombay Stock Exchange (BSE).

The share price has seen a 52-week high of Rs 363 and a low of Rs 256 on BSE.

Current EPS & P/E ratio stood at 12.29 and 25.62 respectively.

Cipla is a famous Indian pharma company, which was established by Khwaja Abdul Hamied as The Chemical, Industrial & Pharma Laboratories in the year.

It is well-known out of India for making low-priced anti-AIDS medications for HIV-positive patients in growing nations.

The company manufactures medications in order to treat heart disease, arthritis, polygenic disorder, weight control, depressive disorder and many other health problems, and its manufactured products are marketed in over 180 nations all over the world.